Radiation added to hormone therapy increases survival for men with prostate cancer
Monday, September 22, 2008 - 07:49
in Health & Medicine
For men with locally advanced prostate cancer the addition of radiation treatment to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent compared to those who have anti-androgen hormone treatment alone, according to a randomized study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Read the whole article on Physorg
More from Physorg
Related
- Radiation added to hormone therapy increases survival for men with prostate cancerMon, 22 Sep 2008, 8:29:41 EDT
- Hormone therapy before radiation seed implants for prostate cancerTue, 23 Sep 2008, 9:15:57 EDT
- Short-term hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patientsMon, 2 Nov 2009, 11:33:00 EST
- Age alone should not be used to determine whether to treat prostate cancer with hormonesWed, 24 Sep 2008, 11:31:03 EDT
- A potential new target for treatment of hormone refractory prostate cancerMon, 6 Apr 2009, 12:22:28 EDT